NPWT vs Conventional Dressings for Hip Surgery Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two types of bandages to determine which aids recovery better after hip surgery. One group will use standard sterile dressings, while the other will use a special bandage called negative pressure wound therapy (NPWT), which might reduce wound issues and infections. Researchers aim to discover if NPWT results in fewer complications and less need for additional surgeries. This trial suits individuals recovering from specific hip surgeries, such as revision total hip arthroplasty (THA) for repairing loose parts or infections, who can have their incision closed without extra skin or muscle work. Participants must be willing to try one of the bandages and attend follow-up visits. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the chance to be among the first to receive this innovative therapy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that negative pressure wound therapy (NPWT) is safe for hip surgery recovery?
Research has shown that negative pressure wound therapy (NPWT) is safe for hip revision surgeries. One study found that NPWT did not cause any problems in these surgeries. Another study found that NPWT helped lower the risk of deep infections after bone surgery. However, some patients experienced blisters while using NPWT.
Overall, NPWT appears to reduce the risk of infection and other wound issues after surgery. It is important to note that minor skin reactions, such as blisters, can occur.12345Why are researchers excited about this trial's treatments?
Researchers are excited about negative pressure wound therapy (NPWT) for hip surgery recovery because it offers a different approach to healing compared to conventional sterile antimicrobial dressings. Unlike standard dressings like AQUACEL, which passively cover the wound, NPWT actively uses suction to promote faster healing and reduce infection risk. This method can potentially lead to more efficient recovery times and better outcomes for patients, making it a promising option in surgical care.
What evidence suggests that NPWT is effective for hip surgery recovery?
Research has shown that Negative Pressure Wound Therapy (NPWT), one of the treatments studied in this trial, can help reduce wound complications after hip surgery. Studies have found that NPWT keeps wounds dry, lowering the risk of infection in 76% of patients. It also results in fewer infections at the surgery site and fewer repeat surgeries compared to regular dressings. This method works by gently removing fluids from the wound, aiding in healing. Overall, NPWT has improved recovery after hip and knee surgeries by reducing the chance of infection and other complications. Participants in this trial will receive either NPWT or Sterile Antimicrobial Dressings, the current hospital standard, to compare their effectiveness in recovery.23678
Who Is on the Research Team?
Denis Nam, MD, MSc
Principal Investigator
Rush University Medical Center
Are You a Good Fit for This Trial?
This trial is for adults over 18 who need a revision of their hip replacement surgery. It's open to those with loose components, bone loss, or fractures needing component changes, and infections treated by various methods. Participants must be able to close the wound normally without grafts and agree to follow-up visits.Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo revision total hip arthroplasty with either NPWT or sterile dressings applied intra-operatively
Follow-up
Participants are monitored for wound complications, infections, and reoperations
What Are the Treatments Tested in This Trial?
Interventions
- Negative Pressure Wound Therapy (NPWT)
- Revision THA
- Sterile Antimicrobial Dressings
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor
3M
Industry Sponsor
Dr. John Banovetz
3M
Chief Medical Officer since 2017
PhD in Inorganic Chemistry from Stanford University, Bachelor's degree in Chemistry from Hamline University
William 'Bill' Brown
3M
Chief Executive Officer
Bachelor's and Master's degrees in Mechanical Engineering from Villanova University, MBA from The Wharton School, University of Pennsylvania